1. Introduction {#s0005}
===============

Next-generation sequencing (NGS) technology has produced immense biological data and has shed light on the path towards personalized medicine ([@bb0005]). NGS technology is used extensively for various applications such as: de novo sequencing, disease mapping, and quantifying expression levels through RNA sequencing etc. ([@bb0010]). The general application of NGS is: SNP and other variations discoveries, whose downstream usefulness is linkage map construction, genetic diversity analyses, association mapping and marker assisted selection. They make up over 90% of all human genetic variations, implicated in phenotype differences, risk to certain diseases and response to drugs. They also serve as popular biomarkers in pharmacogenomic studies to understand inter-individual differences in response to various treatments. Even synonymous SNPs also influence mRNA stability, protein conformation and protein regulation ([@bb0015]). Therefore, it is essential to obtain accurate SNP and INDEL profile information through advanced methods such as next-generation sequencing technologies ([@bb0020]). (See [Fig. 1](#f0005){ref-type="fig"}.)

The airway epithelium constitutes an essential tissue barrier protecting the lung from inhaled environmental challenges. Tobacco smoking is the dominant causative for lung/pulmonary cancer and because of this, the epithelial cells of the respiratory tract were impaired in lung cancer patients ([@bb0025], [@bb0035], [@bb0040], [@bb0045]). It creates a field of injury in epithelial cells that line the respiratory tract and is a causative factor for chronic obstructive pulmonary disease and lung cancer, with 10% to 20% of smokers developing these diseases. A smoking-related gene and miRNA expression alteration in the cytologically normal large and small airway epithelium has been proved by using microarray experiments. These expression alterations have been categorized by their degree of reversibility upon smoking cessation, providing insights into genomic changes that may account for persistent lung cancer risk. Similar gene expression alterations have been found in the epithelia of the nose and mouth of smokers ([@bb0050]). The serious challenge in lung cancer is that the early detection and anomalous changes in the immune system, persistent inflammation, alteration in chemokine receptor signaling and cytokine trafficking are the most essential features in disease pathogenesis ([@bb0055], [@bb0060], [@bb0065], [@bb0070], [@bb0075], [@bb0080], [@bb0085], [@bb0090]). Genes S100A8 and S100A9, which are known to be involved in the inflammatory response in the lung, and CYP4F2, a member of the cytochrome P450 family of enzymes that play a role in xenobiotic pathways, were found to be upregulated in smokers by both RNA-Seq and qRT-PCR. Similarly, the expression of the CCL20, IL8, NFKB1A, and SCGB3A1 immunomodulatory genes were found to be upregulated in the normal airway of patients with lung cancer ([@bb0055]).

Genes involved in lung cancer from literature studies were collected and the most relevant genes in lung cancer include the following: *EGFR*, *KRAS*, *MET*, *LKB1*, *BRAF*, *PIK3CA*, *ALK*, *RET*, and *ROS1*. Other frequently mutated genes include tyrosine kinases such as EGFR homolog ERBB4 and multiple ephrin receptor genes such as EPHA3, VEGFR2 (KDR), and NTKR. Recent advances in the fields of mutational analysis and molecularly targeted therapy made it possible to develop new receptor kinase inhibitors such as erlotinib and gefitinib (against EGFR) and most recently crizotinib (against ALK) and antibodies such as ascetuximab (against EGFR) and bevacizumab (against VEGF).

In the current study, SNPs and INDELs were analyzed in four different categories of samples (healthy never smokers, current smokers, smokers with lung cancer and smoking without lung cancer) processed by RNA Seq technology, these following data procured from Frank Schembri et al., 2011 ([@bb0025]). Reads were pre-processed by quality checking and filtering of low quality reads. The processed paired-end reads were mapped to reference genome hg19. Reads that mapped to reference were detached and the replica reads were removed to knock out the false SNPs and INDELs. SNP calling was implemented with default parameters and it was annotated to predict the functional impact of variants. Genes that showed distinctive expression by differential expression, gene analysis and substantiated through microarray were reported earlier in these samples ([@bb0025]). The variants existing in the samples and SNPs/INDELs which are expedient to cause lung cancer in smoking person were identified. This is only a preliminary analysis and further in depth data analysis and wet lab experiments would help for further validation.

2. Materials and methods {#s0010}
========================

2.1. Source of NGS data {#s0015}
-----------------------

The mRNA/transcriptome sequence of human airway epithelial cells was attained in the interim of bronchoscopy undergoing lung nodule resection surgery. These data were retrieved from prior study tabulated in [Table 1](#t0005){ref-type="table"} ([@bb0025]). The reads were paired-end and sequenced through pooled sequence approach using Illumina technology.

The differential expression analysis was performed in these samples. The genes that are differently expressed by RNA differential expression analysis and microarray analysis between these samples are tabulated in [Table 2](#t0010){ref-type="table"}. Pathways and molecular functions such as oxidoreductase activity, metabolism of xenobiotics by cytochrome P450 and retinol metabolism were enriched among genes differentially expressed between current and never smokers. Cytokine--cytokine receptor interaction, chemokine signaling pathway, and cell adhesion molecules were enriched among genes differentially expressed between smokers with and without cancer. The differential expressed genes may be induced by other alternations such as fusion genes, copy number variations and methylation.

2.2. Data retrieval {#s0020}
-------------------

The next generation paired-end sequencing data were procured from the DDBJ DRA database. The data are freely accessible with the successive accession numbers SRR192333, SRR192334, SRR192335, SRR192336 for four different categories of samples such as healthy never smokers, healthy current smokers, smokers without lung cancer and smokers with lung cancer which have been analyzed in this investigation.

2.3. Pre-processing {#s0025}
-------------------

Next generation sequencing approach generates plenty of sequence data in a single experimental run. Hence the data encompasses sequence artifacts that include read errors, poor quality reads and primer/adaptor contamination which have an impact on downstream investigation. Henceforth the quality of data is very decisive otherwise they may lead to spurious conclusions. The initial step after accomplishing the sequencing run is to assess the base quality and to trim or correct bases that do not reconcile the delineated from required specification. Pre-processing was executed using NGSQC toolkit to assess the quality of the data, examine the distribution of nucleotide, and percolate the low quality reads based on sequence constitution ([@bb0095]).

2.4. Alignment/mapping {#s0075}
----------------------

Various groups effectively developed algorithms and software kit to execute alignment and mapping. In this work, we used Burrows--Wheeler Aligner to efficiently align short sequencing reads versus human reference genome hg19 ([@bb0100], [@bb0105]). The accurately mapped reads were detached using the Filter SAM program in SAMtools and the duplicates were discarded using Mark duplicates in Picard tool ([@bb0110]).

2.5. Variant calling {#s0030}
--------------------

SNP, INDEL and structural divergent regions were precisely pinpointed using a variant calling process between four different categories of samples and the reference genome. In this study, we implemented variant calling using Genome Analysis Toolkit Unified Genotypic caller (GATK-UGT) ([@bb0115]) and alignments were recalibrated around insertion/deletion region according to Freud-scaled quality scores. GATK-UGT generates output in VCF format. Along with the SNP and its position, it also reports additional information about the called SNPs, such as quality by depth (coverage), mapping quality, read depth, and genotype quality that represent the quality of the called SNPs ([@bb0120], [@bb0020]).

2.6. Variant annotation {#s0035}
-----------------------

It is essential to envision that the possibility of the functional impact of variants in an automated fashion is becoming progressively critical. The tools used for annotation are as follows: ANNOVAR is an efficient tool to elucidate functional residual of genetic variation and illustrated based on gene and its location and type of variation ([@bb0130]). SIFT was used to predict the effect of amino acid substitutions on the protein function ([@bb0135]). PolyPhen-2 detects the impact of structural changes intern how it is affecting the protein function by divergent sequence and homology based phylogenetic methods ([@bb0140]).

3. Results and discussion {#s0040}
=========================

A simple pipeline to perceive SNPs and INDELs includes, pre-processing the sequence data and filtering low quality bases, mapping reads to the human reference genome, and post-processing of the alignment results in order to find the effect of variation.

3.1. Pre-processing {#s0045}
-------------------

Initially the sequencing quality was scrutinized using FastQC tool. NGSQC toolkit was used to filter the low quality reads and discard the primer/adapter contaminated reads with default parameters. After filtering based on the quality score, 20.2 million reads in healthy never smokers, 10.3 million reads in healthy current smokers, 10.8 million reads in smokers without lung cancer and 10.7 million reads in smokers with lung cancer were retained and used for further analysis.

3.2. Alignment {#s0050}
--------------

Short sequencing reads were mapped to the annotated human reference genome (hg19) using BWA with the default parameters. Properly mapped reads were separated from the unmapped reads using Filter SAM by setting the flag values in SAMtool. The main rationales for these unmapped reads are sequencing flaws, uneven quality of the sample preparations, physical gap of the reference and the defined mapping criteria. SAMtools flagstat was used to implement elementary statistics on aligning binary alignment (BAM) files. Among 44,503,612 reads, about 89.36% were aligned against hg19 and the properly mapped reads were 72.95% in healthy never smokers. Among 27,548,608 reads about 87.74% were aligned and properly mapped reads were 71.48% in healthy current smokers. Among 37,108,950 reads about 90.72% were aligned and properly mapped reads were 77.13% in smokers without lung cancer. Among 35,174,558 reads about 90.92% were aligned and properly mapped reads were 77% in smokers with lung cancer. After performing alignment, SAMtools was used to remove duplicate reads ([@bb0110]).

Short-read alignment tools often misalign reads around INDELs, which in many cases results in mismatches. Local realignment around INDELs revamps the accuracy of INDEL calling. Local realignment, eliminates millions of mostly false positive variants while preserving nearly all truly variable sites. To attain perfect call set possible realignment and recalibration were done using INDEL REALIGNER and TABLE RECALIBRATION tools incorporated within GATK. The recalibrated alignment files were then used for SNP disclosure.

3.3. Variant calling {#s0055}
--------------------

### 3.3.1. SNP/INDEL calling and annotation {#s0060}

The variant discovery software suite developed by the 1000 Genomes Project, the Genome Analysis Tool Kit Unified genotype caller (GATK-UGT) was used to identify SNPs and INDEL. GATK shows a relatively higher positive calling rate and sensitivity when compared to the others, and tends to call more SNPs and lower the false detection. The number of SNPs identified using GATK-UGT is tabulated in [Table 3](#t0015){ref-type="table"}.

It was proclaimed that Ti/Tv ratio for a random variation resulting from systematic errors in the sequencing technology, alignment artifacts and data processing failures should be close to 0.5 ([@bb0145], [@bb0150]). In the current study, transition to transversion ratio ranges from 1.81 to 1.88 that signifies that SNPs were likely resulting from true nucleotide polymorphism. SNP was sorted based on functional classes as missense, nonsense and silent mutations. Missense mutation was higher than silent and non-sense mutations. The number of missense mutations in healthy never smokers was 8571, healthy current smokers was 3005, smokers without lung cancer was 3725 and smokers with lung cancer was 3930. Further analysis with this missense mutation can identify mutated genes culpable for disease. Using ANNOVAR, annotation was performed against dbSNP to identify the known SNPs. SNPs which were not found in dbSNP are considered to be novel. The number of known and novel SNPs/INDEL was tabulated in [Table 4](#t0020){ref-type="table"}. INDEL was called using GATK tool with the default parameters. All the QUAL scores were found to be greater than 30 and read depth approximately ranges from 20--250 which was ordinarily used as principle for calling variants in GATK. The number of insertions was found to be double than deletions in all samples. INDEL annotation was performed using an ANNOVAR tool to discover the known and novel INDELs and is tabulated in [Table 4](#t0020){ref-type="table"}.

The annotation was performed based on genomic location and the SNPs and INDELS were distributed in exonic, intronic, intergenic, downstream, upstream, UTR3, UTR5, and splicing region. SNPs/INDELs found in the exonic region are of most influential, variation in the coding region leads to protein non-functional and it is tabulated in [Table 5](#t0025){ref-type="table"}. INDELs found in exonic region were classified into groups as frameshift deletion and insertion, non-frameshift deletion and insertion and are tabulated in [Table 5](#t0025){ref-type="table"}. The frameshift mutation results in abnormal protein products and changes the function and its regulation.

### 3.3.2. Analysis of differentially expressed genes {#s0065}

SNPs and INDELs were found in the following genes such as S100A8, S100A9, IL8, NFKB1A, SCGB1A1 and SCGB3A1. CYP4F2, CCL20, RP11-295J3.2, and CTD-2325P2.2 genes do not have any SNPs and INDELs. S100A8 and S100A9 genes are calcium and zinc binding proteins, which play a prominent role in regulation of inflammatory response as well as in cancer development and differential expression of these genes is associated with the disease cystic fibrosis ([@bb0145], [@bb0150], [@bb0155], [@bb0160], [@bb0165], [@bb0170]). IL8 plays an essential role in pathogenesis of bronchiolitis, a common respiratory tract disease. NFKB1A is involved in inflammatory response and cancer. SCGB1A1 is a member of secretoglobin family and defects in this gene are associated with susceptibility to asthma, lung disease, respiratory failure etc. ([@bb0175]). SCGB3A1 is involved in regulation of cell proliferation and includes cytokine activity. The number of SNPs and INDELs found within these differential expressed genes is tabulated in [Table 6](#t0030){ref-type="table"}.

S100A8, S100A9, IL8, NFKB1A and SCGB3A1 genes were upregulated in the disease pathogenesis. Based on the category of sample the common variation which is present in smokers with lung cancer, smokers without lung cancer and current smokers was tabulated in [Table. 7](#t0035){ref-type="table"}. These variations were not observed in healthy never smokers and the following changes detected in regulatory region that may affect the regulation of the gene.

When evaluating the changes between smokers with lung cancer and without lung cancer, we detect some discrepancy in the IL8 regulatory region. By comparing the entire sample, some of the variations are present only in smokers with lung cancer.

The effect of non-synonymous aberrations can be anticipated using SIFT and PolyPhen-2. SIFT predicts the potential impact of amino acid substitution on protein function based on sequence homology. PolyPhen-2 also detects the effect of non-synonymous variation based on homologous sequence and structure based prediction. SNP present in this position 180,017,251, amino acid changes alanine to serine predicted to be deleterious based on Polyphen-2 prediction. Frameshift insertion in the position 180,017,797 envisioned to be damaging the protein function. The above SNPs were not reported in catalogue of somatic mutation in cancer (COSMIC) database ([@bb0180]).

4. Conclusion {#s0070}
=============

Transcriptome analysis using next generation sequencing is the most competent and cost effective for identification of SNPs and INDELs. In the current study, our main focus was to analyze the variants existing in the genes which were disclosed earlier as differentially expressed. We found 5 SNPs and 2 INDELs in SCGB1A1, SCGB3A1 and NFKB1A genes which were present only in smokers with lung cancer. Hence a smoking person having this set of SNPs and INDELs is a preliminary signature for the disease pathogenesis. Understanding an individual\'s genetic makeup is believed to be the key role in personalized medicine to maximize drug efficacy and minimize adverse side effects. In the future, an individual\'s genome will be sequenced to predict the future health of the individual and to develop personalized medical treatments that are tailored to work with the genetic variation that is detected ([@bb0185]). Extending this study to a large group of population will be useful for developing personalized medicine. In the future, we are planning to study the stability of wild and mutant protein for secretoglobin using extensive molecular dynamics study in order to find the effect of frameshift and non-synonymous mutation in structural level.
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![Schematic representation of workflow of this current study.](gr1){#f0005}

###### 

Details of samples used for NGS data analysis.

  Data accession   Category                      Details           Age       Status
  ---------------- ----------------------------- ----------------- --------- --------------------------------------------
  SRR192333        Healthy never smokers         3 female          \~ 29     Healthy normal
  SRR192334        Current smokers               1 male 2 female   \~ 41.7   Smokers
  SRR192335        Smokers without lung cancer   1 male 2 female   \~ 49     2 former and 1 current smokers
  SRR192336        Smokers with lung cancer      2 male 1 female   \~ 64.7   2 former and 1 current smokers with cancer

###### 

List of differentially expressed genes in diverse sample.

  gene symbol    Gene name         Location                         Gene expression/sample
  -------------- ----------------- -------------------------------- ----------------------------------------------------------------------
  S100A8         Calgranulin A     Chr1: 153,362,50--153,363,664    Upregulation in smokers
  S100A9         Calgranulin B     Chr1: 153,330,330--153,333,503   Upregulation in smokers
  CYP4F2         Cytochrome p450   Chr19: 15,988,834--6,008,885     Upregulation in smokers
  NFKB1A1        NFKB inhibitor    Chr14: 35,870,717--35,873,952    Upregulation in smokers with lung cancer
  SCGB1A1        Secretoglobin     Chr11: 62,172,575--62,190,667    Differentially expressed smokers with lung cancer
  SCGB3A1        Secretoglobin     Chr5: 180,017,103--180,018,540   Upregulation in smokers with lung cancer
  CCL20          Chemokine         Chr2: 228,678,558--228,682,272   Upregulation in smokers with lung cancer
  IL8            Interleukin 8     Chr4: 74,606,223--74,609,433     Upregulation in smokers with lung cancer
  RP11-295J3.2   ncRNA             Chr10: 127,660,757--27,661,695   Down regulation in smokers with lung cancer and smokers
  CTD-2325P2.2   Pseudogene        Chr14: 69,159,807--69,160,300    Upregulation in smokers with lung cancer, Down regulation in smokers

###### 

Number of SNPs present in four categories.

  Category                      SNP      Transition   Transversion   Ti/Tv ratio
  ----------------------------- -------- ------------ -------------- -------------
  Healthy never smokers         85,028   55,314       29,714         1.86
  Healthy current smokers       32,671   21,185       11,486         1.84
  Smokers without lung cancer   50,205   32,820       17,385         1.88
  Smokers with lung cancer      51,299   33,063       18,236         1.81

###### 

Number of Known and Novel SNPs/INDEL present in all the four categories.

  Category                      Total SNPs   Known SNPs   Novel SNPs   Total INDELs   Known INDELs   Novel INDELs
  ----------------------------- ------------ ------------ ------------ -------------- -------------- --------------
  Healthy never smokers         85,028       37,635       47,393       5738           2305           3433
  Healthy current smokers       32,671       14,396       18,275       1561           654            910
  Smokers without lung cancer   50,205       21,914       28,291       3008           1300           1708
  Smokers with lung cancer      51,299       21,451       29,848       3138           1363           1775

###### 

SNPs/INDEL present in exonic/functional region.

  Category                      Synonymous-SNP   Non-synonymous-SNP   Frameshift deletion   Frameshift insertion   Non-frameshift deletion   Non-frameshift insertion
  ----------------------------- ---------------- -------------------- --------------------- ---------------------- ------------------------- --------------------------
  Healthy never smokers         3116             3234                 71                    230                    10                        24
  Healthy current smokers       1419             1429                 23                    71                     4                         9
  Smokers without lung cancer   1830             2061                 46                    107                    4                         19
  Smokers with lung cancer      1902             2058                 48                    116                    5                         13

###### 

Number of SNPs and INDELs present in differentially expressed genes.

  Category                      SNPs   INDELs
  ----------------------------- ------ --------
  Healthy never smokers         39     14
  Healthy current smokers       29     3
  Smokers without lung cancer   27     7
  Smokers with lung cancer      43     10

###### 

SNPs and INDELs present in different categories.

  Chr   Position      dbSNP         Ref/Alt   Category        Location   Gene      Type
  ----- ------------- ------------- --------- --------------- ---------- --------- ----------------------
  1     153,333,376   Novel         A/C       CS + SNL + SL   UTR3       S100A9    NA
  4     74,606,669    rs2227307     T/G       CS + SNL + SL   Intronic   IL8       NA
  1     153,362,719   Novel         T/TC      CS + SNL + SL   Intronic   S100A8    Frameshift insertion
  4     74,607,910    rs2227543     C/T       SNL + SL        Intronic   IL8       NA
  4     74,608,162    Novel         T/A       SNL + SL        Intronic   IL8       NA
  4     74,608,163    Novel         T/G       SNL + SL        Intronic   IL8       NA
  4     74,608,408    Novel         C/CA      SNL + SL        UTR3       IL8       NA
  11    62,186,542    rs3741240     G/A       SL              UTR5       SCGB1A1   NA
  11    62,190,293    rs191704193   G/A       SL              Intronic   SCGB1A1   NA
  5     180,017,251   Novel         C/A       SL              Exonic     SCGB3A1   Nonsynonymous SNV
  5     180,017,252   Novel         C/G       SL              Exonic     SCGB3A1   Synonymous SNV
  5     180,017,597   Novel         T/C       SL              Intronic   SCGB3A1   NA
  14    35,871,168    Novel         C/CT      SL              UTR3       NFKB1A    NA
  5     180,017,797   Novel         G/GA      SL              Exonic     SCGB3A1   Frameshift insertion

NA: not Available, CS: current smokers, SNL: smokers with no lung cancer, SL: smokers with lung cancer.
